Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 2 48-2, 2000, Pages

  Thorin, Eric ^a   Lucas, Martin ^a   Cernacek, Peter ^a   Dupuis, Jocelyn ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Chronic heart failure; Endothelin receptor A; Endothelin 1; LU 135252; Rat cerebral artery; Sarafotoxin 6c; Sodium nitroprusside

Indexed keywords

DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; SARAFOTOXIN S6C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BRAIN ARTERY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART HEMODYNAMICS; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC VASCULAR RESISTANCE;

EID: 0033862993     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.2.h844     Document Type: Article

References (34)

1. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
2. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta
3. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor
4. 2+(i) in vascular smooth muscle by inhibition of calcium current
5. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle cells
6. Enhanced coronary vasoconstriction to endothelin-B-receptors activation in experimental chronic heart failure
7. 2+ influx
8. Interaction between nitroglycerin and endothelium in vascular smooth muscle relaxation
9. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles
10. Endothelial dysfunction: Clinical implication
11. Nitrates in the treatment of heart failure
12. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure
13. 2+-independent activation of the endothelial nitric oxide sythase
14. Inhibition of the endothelium-dependent relaxation by 18 beta-glycyr-rhetinic acid in the guinea pig aorta
15. The novel non-peptide selective endothelin A receptor antagonist LU 135252 protects against myocardial ischaemic and reperfusion injury in the pig
16. Prolonged blockade of endothelin ET(A) receptors decreases vascular reactivity in the aorta of spontaneously hypertensive rats in vitro
17. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance
18. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ET(A) receptor blockade in chronic heart failure patients treated with ACE inhibitors
19. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo
20. Role of endogenous endothelin in chronic heart failure. Effect of long-term treatment with endothelin antagonist on survival, hemodynamics, and cardiac remodelling
21. Evidence for a role of endothelin I and protein kinase C in nitroglycerin tolerance
22. Endothelin A receptor blockade causes adverse left ventricular remodeling but iraproves pulmonary artery pressure after infarction in the rat
23. cGMP-dependent protein kinase activates Ca-sensitive K channels in cerebral artery smooth muscle cells
24. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
25. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: Marked increase in endothelin-1 production in the failing heart
26. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate
27. Concomitant endothelin receptor sub-type-A blockade during the progression of pacing-induced congestive heart failure in rabbits, Beneficial effects on left ventricular and myocyte function
28. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
29. Endothelin-1 regulates tone of isolated small arteries in the rat: Effects of hyperendothelinemia
30. 2-adrenoceptor-mediated endothelium-dependent vasodilatation
31. Altered coronary wall and vasomotion six week postangioplasty and irradiation therapy
32. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans
33. Comparison of the effects of selective ET(A) and ETB receptor antagonists in congestive heart failure
34. Effects of specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure. Comparison of effects with those of endothelin A receptor antagonism